T63.314D Toxic effect of venom of black widow spider, undetermined, subsequent encounter

Name of the Condition

• Toxic effect of venom of black widow spider, undetermined, subsequent encounter

Summary

This condition describes adverse health effects resulting from exposure to black widow spider venom, typically through a bite, during a subsequent encounter. The effects can range from localized reactions to systemic toxicity, depending on the dose and individual response. The "undetermined" classification indicates the intent or circumstances of exposure were not specified, and "subsequent encounter" denotes care for a condition with ongoing effects or after the acute phase.

Causes

Exposure to black widow spider venom occurs when the spider injects venom into the body, usually via a bite. Venom contains neurotoxins that can affect the nervous system, leading to localized or systemic reactions. The "undetermined" modifier implies the intent or context of exposure was not documented, while "subsequent encounter" reflects ongoing management of residual effects.

Risk Factors

• Outdoor activities in regions with black widow spiders.
• Handling or disturbing spiders, including in storage areas or outdoor spaces.
• Lack of protective measures (e.g., gloves, closed footwear) in high-risk environments.
• Occupational exposure (e.g., construction, gardening).

Symptoms

• Localized pain, swelling, or redness at the bite site.
• Muscle spasms, cramping, or rigidity (especially in the abdomen or back).
• Systemic effects like nausea, dizziness, or sweating.
• Neurological symptoms (e.g., muscle weakness, paralysis) in severe cases.

Diagnosis

Clinical evaluation of symptoms and exposure history. Identification of bite marks or spider contact. Laboratory tests (e.g., blood work) may assess systemic effects. The "subsequent encounter" modifier indicates the patient is receiving care for a condition with ongoing effects or after the acute phase, while "undetermined" reflects unspecified intent or circumstances of exposure.

Treatment Options

• Symptomatic management of residual effects (e.g., pain relief, muscle relaxants).
• Monitoring for delayed complications.
• Referral to specialists if neurological or systemic symptoms persist.

Prognosis and Follow-Up

Most patients recover fully with appropriate care, but some may experience lingering symptoms. Follow-up ensures resolution of symptoms and addresses any delayed complications. The "subsequent encounter" modifier applies to encounters for care related to the condition after the acute phase.

Complications

• Persistent pain or muscle spasms.
• Neurological deficits (e.g., weakness, paresthesia).
• Allergic reactions or anaphylaxis (rare).

Lifestyle & Prevention

• Wear protective clothing (e.g., gloves, long sleeves) in high-risk areas.
• Inspect and shake out clothing or shoes before use.
• Seal cracks and crevices to reduce spider habitats.
• Avoid provoking spiders.

When to Seek Professional Help

Seek care if symptoms worsen, new symptoms develop, or if there are signs of systemic toxicity (e.g., difficulty breathing, severe muscle spasms). Follow-up is recommended for persistent symptoms after the acute phase.

Tips for Medical Coders

Use T63.314D for encounters related to the toxic effect of black widow spider venom when the intent is undetermined and the encounter is subsequent. Document the clinical context (e.g., residual symptoms, follow-up care) to support the "subsequent encounter" modifier. Ensure the "undetermined" modifier is applied when the circumstances of exposure are not specified.